Monkey pox in Switzerland – Dialogai calls for the authorization of vaccines without delay

– Dialogai calls for the authorization of vaccines without delay

The homosexual association deplores the insufficient commitment of the health authorities to counter the epidemic of monkeypox.

Posted today at 3:57 p.m.

A man receives a dose of monkeypox vaccine in Paris on August 1, 2022.

KEYSTONE/EPA/CHRISTOPHE PETIT TESSON

Dialogai on Wednesday asked Swiss health authorities to react quickly to stem the spread of monkeypox. According to the homosexual association, the cases are constantly increasing and it is necessary “without delay” to authorize the vaccines and the treatments which have already proven their effectiveness in other countries.

Monkeypox can affect anyone, but certain population groups are at higher risk. Many sufferers are men who have sex with men. Sex workers are also at risk, notes Dialogai in a press release.

To date, 298 cases of monkeypox have been confirmed in Switzerland. According to Loïc Michaud, the nurse in charge of the Dialogai CheckPoint in Geneva, “if the disease is considered mild due to its low mortality rate, it can cause significant pain”, which can sometimes lead to hospitalization.

“Insufficient commitment”

Dialogai deplores “an insufficient commitment by the Swiss health authorities” to counter the epidemic. The association points out that in many regions of the world, including the European Union, a third-generation smallpox vaccine has been authorized and that it offers good protection against monkeypox.

Dialogai regrets that this vaccine has not been authorized to date in Switzerland. According to the association, the Confederation must react without delay and centralize the purchase of vaccines to make them available to the medical profession. “It is urgent to initiate a targeted vaccination campaign” for people at risk.

ATS

You found an error?Please let us know.

0 comments